De Vos Anick, Van De Velde Hilde, Joris Hubert, Verheyen Greta, Devroey Paul, Van Steirteghem André
Centre for Reproductive Medicine, University Hospital, Dutch-speaking Brussels Free University, Brussels, Belgium.
Fertil Steril. 2003 Jan;79(1):42-8. doi: 10.1016/s0015-0282(02)04571-5.
To evaluate the influence of morphology of individual spermatozoa on fertilization and pregnancy outcome.
Retrospective analysis.
An IVF center in an institutional research environment.
PATIENT(S): Fertilization and embryo quality according to individual sperm morphology were analyzed in 662 consecutive ICSI cycles. Pregnancy outcome was evaluated for these cycles and an additional 1005 consecutive ICSI cycles.
INTERVENTION(S): ICSI was performed using sperm cells of ejaculated, epididymal, or testicular origin. Observation through an inverted microscope was used to prospectively classify injected sperm cells as normal or morphologically abnormal.
MAIN OUTCOME MEASURE(S): Oocyte fertilization, embryo morphology, and pregnancy outcome of unmixed embryo transfers.
RESULT(S): Injection of morphologically abnormal spermatozoa (irrespective of origin) resulted in a lower fertilization rate (60.7%) than did injection of morphologically normal spermatozoa (71.7%). Embryo cleavage quality did not differ between groups. Higher pregnancy and implantation rates were obtained in patients with normal sperm morphology (36.7% and 18.7%, respectively) than in those with abnormal sperm morphology (20.2% and 9.6%).
CONCLUSION(S): Individual sperm morphology assessed at the moment of ICSI correlated well with fertilization outcome but did not affect embryo development. The implantation rate was lower when only embryos resulting from injection of an abnormal spermatozoon were available.
评估单个精子形态对受精及妊娠结局的影响。
回顾性分析。
机构研究环境中的一家体外受精中心。
对662例连续的卵胞浆内单精子注射(ICSI)周期中根据单个精子形态的受精及胚胎质量进行分析。对这些周期以及另外1005例连续的ICSI周期评估妊娠结局。
使用射出、附睾或睾丸来源的精子细胞进行ICSI。通过倒置显微镜观察将注射的精子细胞前瞻性地分类为正常或形态异常。
未混合胚胎移植的卵母细胞受精、胚胎形态及妊娠结局。
注射形态异常的精子(无论来源)导致的受精率(60.7%)低于注射形态正常的精子(71.7%)。两组间胚胎分裂质量无差异。精子形态正常的患者的妊娠率和着床率(分别为36.7%和18.7%)高于精子形态异常的患者(20.2%和9.6%)。
在ICSI时评估的单个精子形态与受精结局密切相关,但不影响胚胎发育。当仅有注射异常精子产生的胚胎可用时,着床率较低。